In-Soo Myeong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
In-Soo Myeong has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Won-Hun Ham
School of Pharmacy, Sungkyunkwan University
2 shared publications - Yun Kim
College of Pharmacy, Daegu Catholic University, Republic of Korea
2 shared publications - Ekyune Kim
College of Pharmacy, Catholic University of Daegu, Gyeongsan 38430, Korea
1 shared publication - Gabbine Wee
Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu 41061, Korea
1 shared publication - Jaewoong Lee
College of Pharmacy, Daegu Catholic University, Gyeongsan 38430, Republic of Korea
1 shared publication - Jeong-Hoon Jang
College of Pharmacy, Daegu Catholic University, Gyeongsan, Korea
1 shared publication
Latest Publications
- Open Access
- 11 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
In vivo evaluation of synthetic cannabinoid JWH-018 derivatives as potential new psychoactive substances
Synthetic cannabinoid receptor agonists constitute a prominent class of new psychoactive substances (NPS), in which minor structural modifications can markedly influence in vivo pharmacological outcomes. In this study, methoxy-substituted derivatives of JWH-018 were synthesized to examine the effect of substitution position on behavioral activity. JWH-018–5-OMe and JWH-018–6-OMe were evaluated using four in vivo assays, including catalepsy, hypothermia, analgesia, and locomotor activity. JWH-018–5-OMe selectively reduced rectal temperature, with limited effects observed in catalepsy, analgesia, and locomotor activity. Notably, JWH-018–6-OMe elicited robust and dose-dependent effects across all four behavioral endpoints, closely resembling the pharmacological profile of the parent compound, JWH-018 . Collectively, these results demonstrate that structural variations on the indole scaffold can produce measurable psychoactive effects, underscoring the importance of continued evaluation of indole-based synthetic cannabinoids within the NPS framework.
- 11 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessIn vivo evaluation of synthetic cannabinoid JWH-018 derivatives as potential new psychoactive substances
Synthetic cannabinoid receptor agonists constitute a prominent class of new psychoactive substances (NPS), in which minor structural modifications can markedly influence in vivo pharmacological outcomes. In this study, methoxy-substituted derivatives of JWH-018 were synthesized to examine the effect of substitution position on behavioral activity. JWH-018–5-OMe and JWH-018–6-OMe were evaluated using four in vivo assays, including catalepsy, hypothermia, analgesia, and locomotor activity. JWH-018–5-OMe selectively reduced rectal temperature, with limited effects observed in catalepsy, analgesia, and locomotor activity. Notably, JWH-018–6-OMe elicited robust and dose-dependent effects across all four behavioral endpoints, closely resembling the pharmacological profile of the parent compound, JWH-018 . Collectively, these results demonstrate that structural variations on the indole scaffold can produce measurable psychoactive effects, underscoring the importance of continued evaluation of indole-based synthetic cannabinoids within the NPS framework.
- Open Access
Toxicokinetic Characterization of MDM Hydantoin via Stable Metabolite DMH: Population Modeling for Predicting Dermal Formaldehyde Formation
MDM hydantoin (MDMH), a formaldehyde-releasing preservative widely used in cosmetics, poses potential health risks due to its conversion to formaldehyde and systemically absorbed metabolites. Current safety assessments lack quantitative exposure data due to rapid degradation of MDMH in biological matrices. In the present study, we developed a validated LC-MS/MS assay for simultaneous determination of MDMH and its stable metabolite DMH in rat plasma, and characterized their toxicokinetics using population modeling following intravenous and transdermal administration. MDMH exhibited extremely rapid elimination (t1/2 = 0.4 ± 0.1 min) with near-complete conversion to DMH (97.6 ± 9.6%), while DMH demonstrated prolonged retention (t1/2 = 174.2 ± 12.2 min) and complete bioavailability (100.9 ± 18.0%) after transdermal application. Population modeling estimated that 84% (relative standard error: 42.8%) of applied MDMH undergoes cutaneous absorption and metabolism to DMH and formaldehyde within skin tissues. This study demonstrates that stable metabolite monitoring combined with population modeling enables toxicokinetic characterization of rapidly degrading compounds following dermal exposure.
Open AccessToxicokinetic Characterization of MDM Hydantoin via Stable Metabolite DMH: Population Modeling for Predicting Dermal Formaldehyde Formation
MDM hydantoin (MDMH), a formaldehyde-releasing preservative widely used in cosmetics, poses potential health risks due to its conversion to formaldehyde and systemically absorbed metabolites. Current safety assessments lack quantitative exposure data due to rapid degradation of MDMH in biological matrices. In the present study, we developed a validated LC-MS/MS assay for simultaneous determination of MDMH and its stable metabolite DMH in rat plasma, and characterized their toxicokinetics using population modeling following intravenous and transdermal administration. MDMH exhibited extremely rapid elimination (t1/2 = 0.4 ± 0.1 min) with near-complete conversion to DMH (97.6 ± 9.6%), while DMH demonstrated prolonged retention (t1/2 = 174.2 ± 12.2 min) and complete bioavailability (100.9 ± 18.0%) after transdermal application. Population modeling estimated that 84% (relative standard error: 42.8%) of applied MDMH undergoes cutaneous absorption and metabolism to DMH and formaldehyde within skin tissues. This study demonstrates that stable metabolite monitoring combined with population modeling enables toxicokinetic characterization of rapidly degrading compounds following dermal exposure.
- 17 January 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (5) , 894-926
Recent advances in the total synthesis of polyhydroxylated alkaloids via chiral oxazines
The flexible synthetic strategy utilizing syn,syn-, syn,anti-, anti,syn-oxazines enabled the synthesis of 30 diverse polyhydroxylated alkaloids.
- 17 January 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (5) , 894-926
Recent advances in the total synthesis of polyhydroxylated alkaloids via chiral oxazines
The flexible synthetic strategy utilizing syn,syn-, syn,anti-, anti,syn-oxazines enabled the synthesis of 30 diverse polyhydroxylated alkaloids.
- Open Access
- 30 November 2023
- Published by Korean Society of Animal Science and Technology in Journal of Animal Science and Technology
- Vol. 65 (6) , 1205-1213
Industrialization possibilities of purified pig sperm hyaluronidase
Journal of Animal Science and Technology (JAST) is a peer-reviewed, open access journal publishing original research, review articles and notes in all fields of animal science. Topics covered by the journal include: genetics and breeding, physiology, nutrition of monogastric animals, nutrition of ruminants, animal products (milk, meat, eggs and their by-products) and their processing, grasslands and roughages, livestock environment, animal biotechnology, animal behavior and welfare.
- 30 November 2023
- Published by Korean Society of Animal Science and Technology in Journal of Animal Science and Technology
- Vol. 65 (6) , 1205-1213
Open AccessIndustrialization possibilities of purified pig sperm hyaluronidase
Journal of Animal Science and Technology (JAST) is a peer-reviewed, open access journal publishing original research, review articles and notes in all fields of animal science. Topics covered by the journal include: genetics and breeding, physiology, nutrition of monogastric animals, nutrition of ruminants, animal products (milk, meat, eggs and their by-products) and their processing, grasslands and roughages, livestock environment, animal biotechnology, animal behavior and welfare.
- Open Access
- 14 June 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 11, 61680-61687
The Drug-Like Molecule Pre-Training Strategy for Drug Discovery
Recent advances in artificial intelligence (AI) have led to the development of transformer-based models that have shown success in identifying potential drug molecules for therapeutic purposes. However, for a molecule to be considered a viable drug candidate, it must exhibit certain desirable properties such as low toxicity, high druggability, and synthesizability. To address this, we propose an approach that incorporates prior knowledge about these properties during the model training process. In this study, we utilized the PubChem database, which contains 100 million molecules, to filter drug-like molecules based on the quantity of drug-likeliness (QED) score and the Pfizer rule. We then used this filtered dataset of drug-like molecules to train both molecular representation (ChemBERTa) and molecular generation models (MolGPT). To assess the performance of the molecular representation model, we fine-tuned the results on the MoleculeNet benchmark datasets. Meanwhile, we evaluated the performance of the molecular generation model based on the generated samples comprising 10,000 molecules. Despite the limited diversity of the pre-training dataset, the models for molecular representation were able to retain at least 90% of their original performance on benchmark datasets, with an additional improvement of 6% in predicting clinical toxicology. In the domain of molecular generation, the model pre-trained on drug-like molecules exhibited a high rate of desirable molecule properties in the unconditionally generated outputs. Additionally, the diversity of generated structures demonstrated notable performance compared to the conditional generation approach. Moreover, the drug-like molecule pre-training strategy is not limited to a specific model or training method, making it a flexible approach that can be easily modified based on the research interests and criteria of interest.
- 14 June 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 11, 61680-61687
Open AccessThe Drug-Like Molecule Pre-Training Strategy for Drug Discovery
Recent advances in artificial intelligence (AI) have led to the development of transformer-based models that have shown success in identifying potential drug molecules for therapeutic purposes. However, for a molecule to be considered a viable drug candidate, it must exhibit certain desirable properties such as low toxicity, high druggability, and synthesizability. To address this, we propose an approach that incorporates prior knowledge about these properties during the model training process. In this study, we utilized the PubChem database, which contains 100 million molecules, to filter drug-like molecules based on the quantity of drug-likeliness (QED) score and the Pfizer rule. We then used this filtered dataset of drug-like molecules to train both molecular representation (ChemBERTa) and molecular generation models (MolGPT). To assess the performance of the molecular representation model, we fine-tuned the results on the MoleculeNet benchmark datasets. Meanwhile, we evaluated the performance of the molecular generation model based on the generated samples comprising 10,000 molecules. Despite the limited diversity of the pre-training dataset, the models for molecular representation were able to retain at least 90% of their original performance on benchmark datasets, with an additional improvement of 6% in predicting clinical toxicology. In the domain of molecular generation, the model pre-trained on drug-like molecules exhibited a high rate of desirable molecule properties in the unconditionally generated outputs. Additionally, the diversity of generated structures demonstrated notable performance compared to the conditional generation approach. Moreover, the drug-like molecule pre-training strategy is not limited to a specific model or training method, making it a flexible approach that can be easily modified based on the research interests and criteria of interest.
- 1 July 2018
- Published by Elsevier in Tetrahedron
- Vol. 74 (28) , 3888-3896
Stereoselective allylation of acyclic and chiral α-amino-β-Hydroxy aldehydes part 2: Application to the formal synthesis of the polyhydroxylated γ-amino acid (+)-Detoxinine
- 1 July 2018
- Published by Elsevier in Tetrahedron
- Vol. 74 (28) , 3888-3896
Stereoselective allylation of acyclic and chiral α-amino-β-Hydroxy aldehydes part 2: Application to the formal synthesis of the polyhydroxylated γ-amino acid (+)-Detoxinine